Chronic Lymphocytic Leukemia — Proceedings from a Symposium Held in Partnership with the American Oncology Network
Hematologic Oncology Update
00:00
Pirtobrutinib frontline adoption considerations
Rogers cautions about sequencing loss if pirtobrutinib is used upfront and prefers it for older patients unlikely to need additional BTKs.
Play episode from 30:11
Transcript
